type: position_score table: filename: ENCFF780LOO.tabix.bed.gz header_mode: none zero_based: true format: tabix chrom: column_index: 0 pos_begin: column_index: 1 pos_end: column_index: 2 scores: - id: TF_ChIP-seq_ENCSR521IID column_index: 3 type: float desc: 'TF_ChIP-seq ENCSR521IID [biosample_summary="Homo sapiens with nonobstructive coronary artery disease; liver tissue male adult (32 years)" and target="MAX"]' histogram: type: number number_of_bins: 100 meta: summary: 'TF_ChIP-seq ENCSR521IID [biosample_summary="Homo sapiens with nonobstructive coronary artery disease; liver tissue male adult (32 years)" and target="MAX"]' description: '**status**: released **biological\_replicates**: Rep 1, Rep 2 **summary**: male adult (32 years) with nonobstructive coronary artery disease **output\_type**: IDR thresholded peaks **audit\_internal\_action**: Released analysis {ENCAN244ADV|/analyses/ENCAN244ADV/} has in progress subobject document {f8ac7dd0-8a0c-4876-9c3e-2fb8f8e90bc6|/documents/f8ac7dd0-8a0c-4876-9c3e-2fb8f8e90bc6/} **audit\_internal\_action**: Released analysis {ENCAN244ADV|/analyses/ENCAN244ADV/} has in progress subobject quality standard {encode4-tf-chip|/quality-standards/encode4-tf-chip/}' labels: reference_genome: hg38/genomes/GRCh38-hg38 accession: ENCSR521IID status: released assay_term_name: ChIP-seq simple_biosample_summary: male adult (32 years) with nonobstructive coronary artery disease biosample_summary: Homo sapiens with nonobstructive coronary artery disease; liver tissue male adult (32 years) replication_type: isogenic biosample_ontology: /biosample-types/tissue_UBERON_0002107/ perturbed: false doi: 10.17989/ENCSR521IID date_created: '2015-09-29T17:33:23.527719+00:00' date_released: '2016-06-30' submitter_comment: 'This experiment is being used in the ENCODE-DREAM Transcription Factor Binding Site Prediction Challenge (https://www.synapse.org/#!Synapse:syn6131484/wiki/400026). The files will be unavailable until after the challenge completes on 09-30-16. UPDATE: There will be a second round to the challenge that is expected to end on 01-11-2017' target: MAX